Earnings History Data for La Jolla Pharmaceutical Company (LJPC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

La Jolla Pharmaceutical Company

LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2021	PM		LJPC	La Jolla Pharmaceutical	118.00	-0.08	-0.07	0.00	La Jolla Pharmaceutical EPS misses by $0.01, misses on revenue [11/4/2021 9:12 AM]	4.08	-0.29 (-6.64%)	4.08	0.0 (0.00%)	3.35 - 7.85	96,153	80,000	157
La Jolla Pharmaceutical EPS misses by $0.01, misses on revenue [11/4/2021 9:12 AM] La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress [Nov-04-21 08:45AM] La Jolla Pharmaceutical (LJPC) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 10:05AM]
07-05-2021	PM		LJPC	La Jolla Pharmaceutical Company	111.00	0.42	0.67	0.00	La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue [5/7/2021 8:54 AM]	3.88	-0.05 (-1.27%)	4.17	0.24 (6.11%)	3.36 - 8.10	262,787	160,000	9,786
La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue [5/7/2021 8:54 AM] La Jolla Pharmaceutical shares rise on Q1 topline beat [5/7/2021 9:22 AM] La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress [May-07-21 08:45AM] La Jolla Pharmaceutical (LJPC) Misses Q1 Earnings Estimates [May-07-21 10:05AM]
08-03-2021	PM		LJPC	La Jolla Pharmaceutical Company	130.06	-0.13	-0.35	-0.93	La Jolla Pharmaceutical EPS beats by $0.21, beats on revenue [3/8/2021 9:16 AM]	4.59	-0.09 (-1.92%)	4.68	0.0 (0.00%)	3.36 - 8.10	233,726	317,309	4,007
La Jolla Pharmaceutical EPS beats by $0.21, beats on revenue [3/8/2021 9:16 AM] La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates [Mar-08-21 10:45AM] La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Corporate Progress [Mar-08-21 08:55AM]
09-11-2020	AH		LJPC	La Jolla Pharmaceutical Company	103.16	-0.43	-0.74	-1.08	La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue [11/9/2020 5:59 PM]	4.14	-0.18 (-4.16%)	4.15	-0.17 (-3.94%)	2.30 - 9.38	309,958	304,322	3,962

06-08-2020	PM	8:30 AM ET (Aug 6)	LJPC	La Jolla Pharmaceutical Company	110.83	-0.57	-0.59	-1.12	La Jolla Pharmaceutical EPS misses by $0.13, misses on revenue [8/6/2020 9:11 AM]	3.60	-0.20 (-5.15%)	3.80	0.01 (0.26%)	2.30 - 11.41	367,864	621,981	141,566